chr2-131491303-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001085365.2(MZT2A):​c.319+573T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.39 in 287,440 control chromosomes in the GnomAD database, including 26,338 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.44 ( 17041 hom., cov: 32)
Exomes 𝑓: 0.34 ( 9297 hom. )

Consequence

MZT2A
NM_001085365.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.630

Publications

9 publications found
Variant links:
Genes affected
MZT2A (HGNC:33187): (mitotic spindle organizing protein 2A) Located in centrosome; cytosol; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
MIR4784 (HGNC:41580): (microRNA 4784) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.746 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MZT2ANM_001085365.2 linkc.319+573T>C intron_variant Intron 2 of 2 ENST00000309451.7 NP_001078834.1 Q6P582

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MZT2AENST00000309451.7 linkc.319+573T>C intron_variant Intron 2 of 2 1 NM_001085365.2 ENSP00000311500.6 Q6P582

Frequencies

GnomAD3 genomes
AF:
0.436
AC:
66075
AN:
151600
Hom.:
16987
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.658
Gnomad AMI
AF:
0.289
Gnomad AMR
AF:
0.552
Gnomad ASJ
AF:
0.384
Gnomad EAS
AF:
0.766
Gnomad SAS
AF:
0.410
Gnomad FIN
AF:
0.319
Gnomad MID
AF:
0.383
Gnomad NFE
AF:
0.274
Gnomad OTH
AF:
0.447
GnomAD4 exome
AF:
0.339
AC:
46008
AN:
135724
Hom.:
9297
Cov.:
0
AF XY:
0.344
AC XY:
24610
AN XY:
71618
show subpopulations
African (AFR)
AF:
0.651
AC:
2512
AN:
3858
American (AMR)
AF:
0.592
AC:
3397
AN:
5734
Ashkenazi Jewish (ASJ)
AF:
0.394
AC:
1329
AN:
3376
East Asian (EAS)
AF:
0.755
AC:
4268
AN:
5656
South Asian (SAS)
AF:
0.387
AC:
8471
AN:
21874
European-Finnish (FIN)
AF:
0.315
AC:
2155
AN:
6838
Middle Eastern (MID)
AF:
0.361
AC:
259
AN:
718
European-Non Finnish (NFE)
AF:
0.264
AC:
21261
AN:
80558
Other (OTH)
AF:
0.331
AC:
2356
AN:
7112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1282
2564
3847
5129
6411
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
290
580
870
1160
1450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.436
AC:
66197
AN:
151716
Hom.:
17041
Cov.:
32
AF XY:
0.444
AC XY:
32911
AN XY:
74128
show subpopulations
African (AFR)
AF:
0.659
AC:
27267
AN:
41406
American (AMR)
AF:
0.552
AC:
8426
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.384
AC:
1328
AN:
3462
East Asian (EAS)
AF:
0.766
AC:
3946
AN:
5150
South Asian (SAS)
AF:
0.412
AC:
1969
AN:
4782
European-Finnish (FIN)
AF:
0.319
AC:
3357
AN:
10538
Middle Eastern (MID)
AF:
0.361
AC:
106
AN:
294
European-Non Finnish (NFE)
AF:
0.274
AC:
18578
AN:
67808
Other (OTH)
AF:
0.453
AC:
956
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1663
3326
4988
6651
8314
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
572
1144
1716
2288
2860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.322
Hom.:
26759
Bravo
AF:
0.467
Asia WGS
AF:
0.583
AC:
2025
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
4.7
DANN
Benign
0.42
PhyloP100
-0.63
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6709245; hg19: chr2-132248876; API